Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Advanced Refractory Solid Tumors × Clear all

NCT03863145 2024-02-07

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Refractory Solid Tumors